Apyx Medical Share Price Today
(NASDAQ: APYX)

Name: Apyx Medical Share Price Today (NASDAQ: APYX) - Apyx Medical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Apyx Medical share price is $1.2 & ₹104.36 as on 6 Mar 2025, 2.30 'hrs' IST

$1.2

▲

0.01

(0.84%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Apyx Medical share price in Dollar and Rupees. Guide to invest in Apyx Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Apyx Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Apyx Medical share price movements

Today's Low: $1.17
Today's High: $1.30
$1.20
2.5%
Downside
Day's Volatility :10.0%
Upside
7.69%
52 Weeks Low: $0.97
52 Weeks High: $2.20
$1.20
19.42%
Downside
52 Weeks Volatility :56.05%
Upside
45.45%

Apyx Medical (APYX) Returns

Period	Apyx Medical Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.71%	2.1%	0.0%
6 Months	-8.46%	-4.1%	0.0%
1 Year	-43.6%	2.2%	0.0%
3 Years	-87.84%	11.8%	-11.6%

Apyx Medical (APYX) Key Statistics

in dollars & INR

Previous Close	$1.19
Open	$1.23
Today's High	$1.3
Today's Low	$1.17
Market Capitalization	$49.7M
Today's Volume	$2.3K
52 Week High	$2.2
52 Week Low	$0.967
Revenue TTM	$48.5M
EBITDA	$-20.7M
Earnings Per Share (EPS)	$-0.82
Profit Margin	-58.59%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-127.39%

How to invest in Apyx Medical Stock (APYX) from India?

It is very easy for Indian residents to invest directly in Apyx Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Apyx Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Apyx Medical or APYX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Apyx Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Apyx Medical shares which would translate to 0.725 fractional shares of Apyx Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Apyx Medical, in just a few clicks!

Returns in Apyx Medical (APYX) for Indian investors in Rupees

The Apyx Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Apyx Medical investment value today

Current value as on today

₹61,835

Returns

₹38,165

(-38.17%)

Returns from Apyx Medical Stock

₹43,128 (-43.13%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Apyx Medical (APYX)

-67%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Apyx Medical Stock from India on INDmoney has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Apyx Medical

Nantahala Capital Management, LLC
8.42%
Archon Capital Management LLC
8.34%
Royce & Associates, LP
6.95%
Vanguard Group Inc
3.92%
Horizon Asset Management Inc/ny
1.63%
Silverberg Bernstein Capital Management LLC
1.52%

Analyst Recommendation on Apyx Medical

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Apyx Medical(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Apyx Medical Stock (APYX)

What analysts predicted

Upside of 150.0%

Target:

$3.00

Current:

$1.20

Insights on Apyx Medical Stock (Ticker Symbol: APYX)

Price Movement
In the last 7 days, APYX stock has moved down by -16.8%
Decreasing Revenue
Revenue is down for the last 5 quarters, 15.97M → 11.48M (in $), with an average decrease of 7.7% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -9.60M → -4.70M (in $), with an average increase of 27.3% per quarter
APYX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 54.6% return, outperforming this stock by 94.5%
APYX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.7% return, outperforming this stock by 223.8%
Price to Sales
ForAPYX every $1 of sales, investors are willing to pay $0.8, whereas for Boston Scientific Corp., the investors are paying $9.1 for every $1 of sales.

APYX Apyx Medical Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$16.7M	↓ 57.09%
Net Income	$64.0M	↓ 1364.5%
Net Profit Margin	383.61%	↑ 396.63%

	FY19	Y/Y Change
Revenue	$28.2M	↑ 68.73%
Net Income	$-19.7M	↓ 130.7%
Net Profit Margin	-69.79%	↓ 453.4%

	FY20	Y/Y Change
Revenue	$27.7M	↓ 1.57%
Net Income	$-11.9M	↓ 39.41%
Net Profit Margin	-42.96%	↑ 26.83%

	FY21	Y/Y Change
Revenue	$48.5M	↑ 75.08%
Net Income	$-15.2M	↑ 27.67%
Net Profit Margin	-31.33%	↑ 11.63%

	FY22	Y/Y Change
Revenue	$44.5M	↓ 8.26%
Net Income	$-23.3M	↑ 53.14%
Net Profit Margin	-52.3%	↓ 20.97%

	FY23	Y/Y Change
Revenue	$52.3M	↑ 17.61%
Net Income	$-18.7M	↓ 19.61%
Net Profit Margin	-35.75%	↑ 16.55%

	Q2 FY23	Q/Q Change
Revenue	$13.6M	↑ 11.75%
Net Income	$-994.0K	↓ 71.86%
Net Profit Margin	-7.33%	↑ 21.76%

	Q3 FY23	Q/Q Change
Revenue	$16.0M	↑ 17.72%
Net Income	$-4.6M	↑ 365.69%
Net Profit Margin	-28.98%	↓ 21.65%

	Q4 FY23	Q/Q Change
Revenue	$14.7M	↓ 8.21%
Net Income	$-9.6M	↑ 107.54%
Net Profit Margin	-65.52%	↓ 36.54%

	Q1 FY24	Q/Q Change
Revenue	$14.5M	↓ 0.84%
Net Income	$-7.6M	↓ 21.14%
Net Profit Margin	-52.11%	↑ 13.41%

	Q2 FY24	Q/Q Change
Revenue	$12.1M	↓ 16.44%
Net Income	$-6.6M	↓ 13.46%
Net Profit Margin	-53.96%	↓ 1.85%

	Q3 FY24	Q/Q Change
Revenue	$11.5M	↓ 5.45%
Net Income	$-4.7M	↓ 28.26%
Net Profit Margin	-40.94%	↑ 13.02%

	FY18	Y/Y Change
Profit	$10.8M	↓ 45.38%

	FY19	Y/Y Change
Profit	$19.1M	↑ 77.22%

	FY20	Y/Y Change
Profit	$17.5M	↓ 8.49%

	FY21	Y/Y Change
Profit	$33.6M	↑ 91.96%

	FY22	Y/Y Change
Profit	$29.1M	↓ 13.3%

	FY23	Y/Y Change
Profit	$33.8M	↑ 15.89%

	Q2 FY23	Q/Q Change
Profit	$9.3M	↑ 22.53%

	Q3 FY23	Q/Q Change
Profit	$8.0M	↓ 14.02%

	Q4 FY23	Q/Q Change
Profit	$4.1M	↓ 49.08%

	Q1 FY24	Q/Q Change
Profit	$5.9M	↑ 46.45%

	Q2 FY24	Q/Q Change
Profit	$2.8M	↓ 52.75%

	Q3 FY24	Q/Q Change
Profit	$7.0M	↑ 147.39%

	FY18	Y/Y Change
Operating Cash Flow	$-21.0M	↑ 467.25%
Investing Cash Flow	$29.3M	↓ 4795.67%
Financing Cash Flow	$-2.5M	↑ 1292.18%

	FY19	Y/Y Change
Operating Cash Flow	$-18.5M	↓ 12.07%
Investing Cash Flow	$60.5M	↑ 106.62%
Financing Cash Flow	$147.0K	↓ 105.9%

	FY20	Y/Y Change
Operating Cash Flow	$-16.1M	↓ 13.04%
Investing Cash Flow	$-581.0K	↓ 100.96%
Financing Cash Flow	$-73.0K	↓ 149.66%

	FY21	Y/Y Change
Operating Cash Flow	$-10.4M	↓ 34.96%
Investing Cash Flow	$-723.0K	↑ 24.44%
Financing Cash Flow	$24.0K	↓ 132.88%

	FY22	Y/Y Change
Operating Cash Flow	$-20.3M	↑ 94.09%
Investing Cash Flow	$-1.0M	↑ 39.7%
Financing Cash Flow	$217.0K	↑ 804.17%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-4.9M	↑ 157.95%
Investing Cash Flow	$7.1M	↓ 6564.55%
Financing Cash Flow	$46.0K	↓ 99.43%

Apyx Medical Technicals Summary

Sell

Neutral

Buy

Apyx Medical is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Apyx Medical (APYX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Apyx Medical Corp	-16.2%	-8.46%	-43.6%	-87.84%	-79.23%
Medtronic Plc	2.26%	4.07%	8.74%	-12.76%	0.68%
Edwards Lifesciences Corp.	0.07%	8.12%	-19.19%	-34.12%	12.08%
Boston Scientific Corp.	0.07%	27.33%	53.68%	143.5%	203.93%
Stryker Corporation	-0.63%	8.92%	9.84%	53.87%	125.87%
Abbott Laboratories	7.11%	21.64%	15.28%	15.75%	78.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Apyx Medical Corp	NA	NA	NA	-0.7	-1.27	-0.22	NA	0.32
Medtronic Plc	28.75	28.75	1.87	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.5	30.5	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	83.9	83.9	1.85	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.89	50.89	2.85	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Apyx Medical Corp	Buy	$49.7M	-79.23%	NA	-58.59%
Medtronic Plc	Buy	$120.9B	0.68%	28.75	12.83%
Edwards Lifesciences Corp.	Buy	$42.0B	12.08%	30.5	76.75%
Boston Scientific Corp.	Buy	$154.8B	203.93%	83.9	11.07%
Stryker Corporation	Buy	$150.7B	125.87%	50.89	13.25%
Abbott Laboratories	Buy	$238.6B	78.63%	18.34	31.95%

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Organization	Apyx Medical
Employees	252
CEO	Mr. Charles D. Goodwin II
Industry	Health Technology

Management People of Apyx Medical

Name	Title
Mr. Charles D. Goodwin II	President, CEO & Director
Mr. Matthew C. Hill CPA	CFO, Treasurer & Secretary
Mr. Moshe Citronowicz	Senior Vice President
Mr. Stavros George Vizirgianakis B.Com.	Executive Chairman
Mr. Shawn D. Roman	Chief Operating Officer

Important FAQs about investing in APYX Stock from India :

What is Apyx Medical share price today?

Apyx Medical share price today stands at $1.20, Open: $1.23 ; Previous Close: $1.19 ; High: $1.30 ; Low: $1.17 ; 52 Week High: $2.20 ; 52 Week Low: $0.97.

The stock opens at $1.23, after a previous close of $1.19. The stock reached a daily high of $1.30 and a low of $1.17, with a 52-week high of $2.20 and a 52-week low of $0.97.

Can Indians buy Apyx Medical shares?

Yes, Indians can invest in the Apyx Medical (APYX) from India.

With INDmoney, you can buy Apyx Medical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Apyx Medical at zero transaction cost.

How can I buy Apyx Medical shares from India?

It is very easy to buy Apyx Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Apyx Medical (APYX) be purchased?

Yes, you can buy fractional shares of Apyx Medical with INDmoney app.

What are the documents required to start investing in Apyx Medical stocks?

To start investing in Apyx Medical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.